Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results

Findings highlight potential to expand oral GLP-1 RA treatment options for patients with type 2 diabetes and obesity NEW ORLEANS, June 8, 2026 /PRNewswire/ -- Findings from two phase 2 studies demonstrated positive outcomes for elecoglipron, an investigational oral, once-daily, small...